4//SEC Filing
Hoelscher Paul W. 4
Accession 0001209191-22-023845
CIK 0001492426other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:09 PM ET
Size
16.4 KB
Accession
0001209191-22-023845
Insider Transaction Report
Form 4
Hoelscher Paul W.
EVP, Finance
Transactions
- Exercise/Conversion
Ordinary Shares
2022-04-06$15.96/sh+30,275$483,189→ 31,324 total - Sale
Ordinary Shares
2022-04-06$110.01/sh−215,335$23,688,788→ 1,049 total - Exercise/Conversion
Ordinary Shares
2022-04-06$22.14/sh+185,060$4,097,228→ 216,384 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-06−30,275→ 0 totalExercise: $15.96Exp: 2024-06-26→ Ordinary Shares (30,275 underlying) - Sale
Ordinary Shares
2022-04-06$110.01/sh−91,710$10,089,026→ 66,673 total(indirect: By LLC) - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-06−185,060→ 86,424 totalExercise: $22.14Exp: 2025-03-22→ Ordinary Shares (185,060 underlying)
Holdings
- 72,789(indirect: By Trust)
Ordinary Shares
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2021.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]These securities are held of record by Riviera Equity LLC. The Reporting Person and his spouse share voting power over the securities held by Riviera Equity LLC.
- [F6]The option is fully vested and exercisable.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001611468
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:09 PM ET
- Size
- 16.4 KB